Feedback / Questions
TERN-701 - Terns Pharma
https://www.globenewswire.com/news-release/2025/12/08/3201903/0/en/Terns-Highlights-Additional-Positive-Phase-1-Clinical-Data-Supporting-TERN-701-s-Best-in-Disease-Potential-in-Relapsed-Refractory-CML-at-the-67th-ASH-Annual-Meeting.html
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next